Malteser Krankenhaus St. Franziskus Hospital
About Malteser Krankenhaus St. Franziskus Hospital
"Die Notaufnahme befindet sich in der Diako, Knuthstraße 1, Flensburg"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
6
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
German CLL Study Group
1
Hoffmann-La Roche
1
III. Medizinische Klinik Mannheim
1
Takeda
1
medac GmbH
1
Clinical Trials at Malteser Krankenhaus St. Franziskus Hospital
During the past decade, Malteser Krankenhaus St. Franziskus Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
2008-11-24
2018-01-25
Completed
570
Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation
2010-05-12
2021-09-01
Completed
600
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
2010-07-01
Recruiting
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
2012-10-01
2018-03-27
Terminated
8
Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)
2014-07-01
2024-02-01
Active, not recruiting
203
Study of Palbociclib in MLL-rearranged Acute Leukemias
2015-07-01
2019-07-01
Unknown status
50
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Malteser Krankenhaus St. Franziskus Hospital" #1 sponsor was "University of Ulm" with 6 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials
sponsored, "German CLL Study Group" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "III. Medizinische Klinik Mannheim"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Malteser Krankenhaus St. Franziskus Hospital"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Jazz Pharmaceuticals" with 1 trials as a collaborator, "National Center for Tumor Diseases, Heidelberg" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Malteser Krankenhaus St. Franziskus Hospital
According to Clinical.Site data, the most researched conditions in "Malteser Krankenhaus St. Franziskus Hospital" are
"Acute Myeloid Leukemia" (7 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Malteser Krankenhaus St. Franziskus Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Malteser Krankenhaus St. Franziskus Hospital
Most popular intervention types in "Malteser Krankenhaus St. Franziskus Hospital" are "Drug" (11 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Cytarabine" (2 trials), "Daunorubicin" (2 trials), "Pemetrexed" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Malteser Krankenhaus St. Franziskus Hospital
The vast majority of trials in "Malteser Krankenhaus St. Franziskus Hospital" are
13 trials for "All" genders.
Clinical Trials Status at Malteser Krankenhaus St. Franziskus Hospital
Currently, there are NaN active trials in "Malteser Krankenhaus St. Franziskus Hospital".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Malteser Krankenhaus St. Franziskus Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Malteser Krankenhaus St. Franziskus Hospital, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".